Cataract Surgery News

KOLOA, Hawaii — At Hawaiian Eye 2020, Jay S. Pepose, MD, PhD, director of Pepose Vision Institute, said that because posterior capsular opacification remains the most common late-term sequelae and effects a patient’s quality of life, the diagnosis, treatment and the timing of treatment are critical.

KOLOA, Hawaii — At Hawaiian Eye 2020, Jim Mazzo, global president of ophthalmic devices at Carl Zeiss Meditec, shares his vision for the next year for Zeiss which is “the only company that diagnoses and treats” and “the world leader in optics.”

NEW YORK — During a presentation at OSN New York 2019, John A. Hovanesian, MD, FACS, discusses a problematic case study.

Keep up to date with the big news in ophthalmology.

NEW YORK — During a presentation at OSN New York 2019, Elizabeth Yeu, MD, discusses how to handle refractive surprises in the operating room after toric IOL implantation.

Although we have enjoyed great success with bilateral extended depth of focus IOLs in patients who want spectacle independence after cataract surgery, I am increasingly opting for a personalized vision combination of the Tecnis Symfony EDOF and a low-add multifocal for the majority of cases.

NEW YORK — During her presentation at OSN New York 2019, Priyanka Sood, MD, discusses mixing and matching IOLs for successful refractive cataract surgery. Understanding advanced technologies and patient desires, as well as setting realistic expectations, are key to success, she said.

NEW YORK — In her presentation at OSN New York 2019, P. Dee G. Stephenson, MD, FACS, ABES, FSEE, explains results of a study that compared retinal imaging with neutral and negative spherical aberration optics.

NEW YORK — Denise M. Visco, MD, MBA, discusses options for astigmatism treatment during cataract surgery in her presentation at OSN New York 2019.

As a new decade begins, Healio.com/OSN looks back at some of our biggest stories in the past 10 years. Over the years, ophthalmology has evolved to include new treatment options, both surgical and pharmaceutical, for numerous conditions affecting every part of the eye.